Success of early antiviral monotherapy with pegylated interferon α-2a for posttransplantation fibrosing cholestatic hepatitis C (a clinical case)

The paper describes a case of posttransplantation fibrosing cholestatic hepatitis C (PFCHC) in a female patient whose transplant was preserved due to timely antiviral therapy (AVT). Its differential diagnosis primarily required that chronic graft rejection and biliary anastomotic stricture be exclud...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Chzhao, O. I. Andreitseva, V. E. Syutkin, A. O. Chugunov, K. R. Dzhagrayev, A. A. Saliyenko, I. V. Aleksandrova, V. V. Artamonov, E. A. Soldatov, L. V. Donova, I. E. Galankina, L. N. Zimina
Format:	Article
Language:	English
Published:	N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:	Трансплантология (Москва)
Subjects:	orthotopic liver transplantation posttransplantation fibrosing cholestatic hepatitis antiviral therapy pegylated interferon α-2a
Online Access:	https://www.jtransplantologiya.ru/jour/article/view/339
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Success of early antiviral monotherapy with pegylated interferon α-2a for posttransplantation fibrosing cholestatic hepatitis C (a clinical case)

Similar Items